New

Astellas Pharma

The AI engine Fit Assessment

Beta

The company holds a patent related to pharmaceutical preparations of human retinal pigment epithelium (RPE) cells, including compositions that may incorporate an angiogenesis inhibitor. Check Source

Blurb

Astellas Pharma develops and commercializes prescription medicines across therapeutic areas.

HQ Location

Tokyo (Japan)

Founded

2005

Employees

10000+

Total funding raised

Not available

Funding Status

Grant, July 22, 2020

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines